Polyendocrine metabolic ovarian syndrome
In most cases, treating the metabolic component improves the hormonal one. That is the order.
Polyendocrine metabolic ovarian syndrome shows up in the cycle, but its engine is usually metabolic. Between 65 and 70 % of women with this diagnosis have insulin resistance, and raised insulin stimulates ovarian androgen production. So the nutritional approach does not start with hormones: it starts with insulin sensitivity.
That has an important practical consequence: the very restrictive diets often recommended tend to worsen the picture over the medium term, because they sacrifice muscle mass, which is precisely the tissue that improves insulin sensitivity.
- Insulin sensitivity prioritised over weight
- Skeletal muscle preservation as a therapeutic goal, not an aesthetic one
- Carbohydrate distribution and quality of source
- Low-grade inflammation addressed through the dietary pattern
- Objective follow-up with medical bioimpedance
This page is educational material from a registered dietitian, not a diagnostic tool. Diagnosis and medical treatment are your doctor’s remit; clinical nutrition accompanies that treatment, it does not replace it.
Frequently asked questions
Not necessarily, and in many cases it is not advisable. The evidence supports improving insulin sensitivity, and several dietary patterns achieve that. Keto is one option, not the only one, and it has a high long-term dropout rate.
It improves the picture considerably when there is excess fat, especially visceral, but how you lose it matters as much as the number. Losing weight at the cost of muscle worsens the metabolic component, and that is where body composition measurement stops being optional.
Book a consultation
- In-person consultationsMon – Fri · 09:00 – 18:00
- Online consultationsSaturday · 09:00 – 14:00
- Payment processingWithin consultation hours
- Booking deposit$20.00 advance deposit
- ReschedulingFree with 24 h notice